Concepedia

Ramakrishnan Natesan

RN

15

Publications

916

Citations

12

H-Index

2014

Active since

Affiliations

University of Pennsylvania(Current)

Cancer Research Institute

University of Michigan

Michigan Center for Translational Pathology

Children's Hospital of Philadelphia

Ramakrishnan Natesan is an author at University of Pennsylvania specializing in cell biology, medicine, and tumor biology.

ORCID

Top concepts

Publications per year

2014–2023

15

Publications

15

Tumor-Derived Retinoic Acid Regulates Intratumoral Monocyte Differentiation to Promote Immune Suppression

Samir Devalaraja, Tsun Ki Jerrick To, Ian W. Folkert et al. · Cell · 2020 · 252 citations · Full text

, , +9

CDK7 Inhibition Suppresses Castration-Resistant Prostate Cancer through MED1 Inactivation

Reyaz ur Rasool, Ramakrishnan Natesan, Qu Deng et al. · Cancer Discovery · 2019 · 131 citations · Full text

Targeting androgen regulation of TMPRSS2 and ACE2 as a therapeutic strategy to combat COVID-19

Qu Deng, Reyaz ur Rasool, Ronnie M. Russell et al. · iScience · 2021 · 100 citations · Full text

Cell Cycle Checkpoints Cooperate to Suppress DNA- and RNA-Associated Molecular Pattern Recognition and Anti-Tumor Immune Responses

Jie Chen, Shane M. Harding, Ramakrishnan Natesan et al. · Cell Reports · 2020 · 98 citations · Full text

Global Regulation of the Histone Mark H3K36me2 Underlies Epithelial Plasticity and Metastatic Progression

Salina Yuan, Ramakrishnan Natesan, Francisco J. Sánchez‐Rivera et al. · Cancer Discovery · 2020 · 86 citations · Full text

Rows per page

1–5 of 15